Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
- Registration Number
- NCT02337062
- Lead Sponsor
- Acacia Pharma Ltd
- Brief Summary
A comparison of the efficacy of APD421 and placebo when combined with a standard anti-emetic in the prevention of PONV in patients at high risk of Post-operative Nausea and Vomiting (PONV).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1147
- Male or female patients β₯ 18 years of age
- Patients undergoing elective surgery (open or laparoscopic technique) under general anaesthesia, expected to last at least one hour from induction of anaesthesia to wound closure
- Patients with at least 3 "Apfel" risk factors for PONV
- Patients scheduled to undergo transplant surgery
- Patients scheduled to receive only a local anaesthetic/regional neuraxial (intrathecal or epidural) block
- Patients who are expected to remain ventilated for a period after surgery
- Patients who are expected to need a naso- or orogastric tube in situ after surgery is completed
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description APD421 + standard anti-emetic APD421 Single dose of IV APD421 Placebo + standard anti-emetic Placebo Single dose of IV placebo
- Primary Outcome Measures
Name Time Method Number of Participants With Complete Response 24 hours after the end of surgery Complete response defined as no emesis and no use of rescue medication in the 24 hour period after end of surgery (defined as wound closure)
- Secondary Outcome Measures
Name Time Method Number of Participants Receiving Rescue Medication 24 hours after the end of surgery Rescue medication defined as an antiemetic (or other medication) given with the intention of relieving nausea and/or emesis, or any incidental use of a drug known to have antiemetic potential
Number of Participants With Significant Nausea 24 hours after end of surgery Nausea (defined as the desire to vomit without the presence of expulsive muscular movements) measured on a 0-10 verbal response scale, where 0=no nausea at all and 10=the worst nausea imaginable. "Significant nausea" means a score β₯ 4.
Time to First Violation of Criteria for PONV 24 hours after end of surgery Criteria for PONV are any episode of emesis or use of rescue medication in the 24 hours after the end of surgery
Number of Participants With Emesis 24 hours after the end of surgery Emesis is defined as vomiting (production of even the smallest amount of stomach contents) or retching (muscular movements of vomiting but without expulsion of stomach contents, usually because of an empty stomach)
Number of Participants With Any Nausea 24 hours after the end of surgery Nausea (defined as the desire to vomit without the presence of expulsive muscular movements) measured on a 0-10 verbal response scale, where 0=no nausea at all and 10=the worst nausea imaginable. "Any nausea" means a score β₯ 1.
Trial Locations
- Locations (25)
Ohio State University
πΊπΈColumbus, Ohio, United States
Stony Brook Medicine
πΊπΈStony Brook, New York, United States
Cleveland Clinic
πΊπΈCleveland, Ohio, United States
Centre Hospitalier de Mulhouse
π«π·Mulhouse, France
UCSF School of Medicine
πΊπΈSan Francisco, California, United States
Helen Keller Hospital
πΊπΈSheffield, Alabama, United States
Centre Hospitalier Lyon-Sud
π«π·Lyon, France
First Street Surgical Center
πΊπΈBellaire, Texas, United States
CHU de Hautepierre
π«π·Strasbourg, France
Brigham and Women's Hospital
πΊπΈBoston, Massachusetts, United States
Memorial Hermann-Memorial City Hospital
πΊπΈHouston, Texas, United States
Jackson Memorial Hospital
πΊπΈMiami, Florida, United States
Duke University Medical Center
πΊπΈDurham, North Carolina, United States
Albany Medical Center Hospital
πΊπΈAlbany, New York, United States
Wake Forest University School of Medicine
πΊπΈWinston-Salem, North Carolina, United States
Victory Medical Center Houston
πΊπΈHouston, Texas, United States
University Hospital
π«π·BesanΓ§on, France
Hopital Foch
π«π·Paris, France
HELIOS Klinikum Aue
π©πͺAue, Germany
UniversitΓ€tsklinikum Bonn
π©πͺBonn, Germany
UniversitΓ€tsmedizin Mainz
π©πͺMainz, Germany
Klinikum Ludwigshafen
π©πͺLudwigshafen, Germany
University Hospitals of WΓΌrzburg
π©πͺWΓΌrzburg, Germany
Philipps University
π©πͺMarburg, Germany
University of Kansas Medical Center
πΊπΈKansas City, Kansas, United States